Mingquan Zhang

Mingquan’s practice focuses on patent and trademark litigation, including proceedings under the Patented Medicines (Notice of Compliance) Regulations , patent infringement / validity proceedings under the Patent Act , and trademark actions. In addition, Mingquan advises clients on patent issues such as infringement and validity. Prior to law school, Mingquan received a B.Sc. in analytical chemistry and a Ph.D. in bioanalytical chemistry.

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,733,908 (ivacaftor).

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,606,282, 2,967,453, and 3,003,988 (dolutegravir-abacavir-lamivudine).

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,606,282 (dolutegravir).

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,671,357 (canagliflozin).

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,534,024 (canagliflozin).